Hepatitis C & injection drug use

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Hepatitis C & injection drug use

Published Date:

February 2015

Language:

English

[PDF-595.35 KB]

Details:

Alternative Title:

Hepatitis C and injection drug use

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Description:

Hepatitis C is a serious liver disease caused by the Hepatitis C virus. About 80% of people who get infected develop a chronic, or lifelong, infection. Over time, chronic Hepatitis C can cause serious health problems including liver damage, liver failure, and even liver cancer. However, some people get only a short term, or acute, infection and are able to clear the virus without treatment. If someone clears the virus, this usually happens within 6 months after first infected.

Subject:

[+]

Document Type:

Pamphlet (or booklet)

Collection(s):

Stephen B. Thacker CDC Library collection

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

Recent HIV clusters and outbreaks across the United States among people who inject drugs and considerations during the COVID-19 pandemic

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

October 5, 2020

Series:

HAN ; 436

Description:

Distributed via the CDC Health Alert NetworkOctober 5, 2020, 11:00 AM ETCDCHAN-00436Since 2015, the Centers for Disease Control and Prevention (CDC) and health departments across the United States have identified several HIV clusters and outbreaks oc...

File Type:

[PDF - 199.46 KB]
2020 National viral hepatitis progress report

Corporate Authors:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Viral Hepatitis.

Published Date:

7/23/20

Description:

The National Viral Hepatitis Progress Report provides information on ten data indicators, providing an objective way to assess progress toward achieving key viral hepatitis goals.Publication date from document properties.NationalProgressReport2020.pd...

File Type:

[PDF - 179.29 KB]
2019 National viral hepatitis progress report

Corporate Authors:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)

Published Date:

09/13/2019

Description:

The National Viral Hepatitis Progress Report provides information on seven data indicators, providing an objective way to assess progress toward achieving key viral hepatitis goals.NationalProgressReport2019.pdf

File Type:

[PDF - 159.20 KB]
Viral hepatitis surveillance United States, 2017

Corporate Authors:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Viral Hepatitis.. National Notifiable Diseases Surveillance System..

Published Date:

9/10/19

Description:

Each week, health departments report cases of hepatitis A, hepatitis B, and hepatitis C to the Centers for Disease Control and Prevention (CDC) through the National Notifiable Diseases Surveillance System (NNDSS). CDC aggregates the information to co...

File Type:

[PDF - 1.85 MB]
Viral hepatitis

Corporate Authors:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)

Published Date:

8/26/19

Description:

The tables below summarize healthcare-associated outbreaks of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection reported in the United States during 2008-2018. Outbreaks previously reported in 1998-2008 can be found in Thompson, et al and...

File Type:

[PDF - 312.06 KB]